Professor Outterson teaches corporate law and health law at Boston University, where he co-directs the Health Law Program, currently ranked #2 in the country by US News.
His research work focuses on the organization and finance of the US health sector. Areas of specialization include global pharmaceutical markets, especially antibiotics and other antimicrobials that can degrade in usefulness over time through resistance. He leads an interdisciplinary project on the legal ecology of antimicrobial resistance, funded in part by the Robert Wood Johnson Foundation program on public health law.
He publishes in both legal journals (Yale Journal of Health Policy, Law & Ethics, Cardozo Law Review, University of Pittsburgh Law Review, Kansas Law Review, American Journal of Law & Medicine) and peer-reviewed medical and health policy journals (Health Affairs, Lancet Infectious Diseases, Environmental Philosophy, Medical Journal of Australia, Journal of Generic Medicines, Clinical Infectious Diseases, Journal of Law, Medicine & Ethics). He is the Editor in Chief of the Journal of Law, Medicine & Ethics and Faculty Advisor to the American Journal of Law & Medicine.
His academic papers can be found at http://ssrn.com/author=340746.